BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 15187889)

  • 1. Genetics of chondrosarcoma and related tumors.
    Sandberg AA
    Curr Opin Oncol; 2004 Jul; 16(4):342-54. PubMed ID: 15187889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular genetic characterization of the EWS/CHN and RBP56/CHN fusion genes in extraskeletal myxoid chondrosarcoma.
    Panagopoulos I; Mertens F; Isaksson M; Domanski HA; Brosjö O; Heim S; Bjerkehagen B; Sciot R; Dal Cin P; Fletcher JA; Fletcher CD; Mandahl N
    Genes Chromosomes Cancer; 2002 Dec; 35(4):340-52. PubMed ID: 12378528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fusion of the RBP56 and CHN genes in extraskeletal myxoid chondrosarcomas with translocation t(9;17)(q22;q11).
    Panagopoulos I; Mencinger M; Dietrich CU; Bjerkehagen B; Saeter G; Mertens F; Mandahl N; Heim S
    Oncogene; 1999 Dec; 18(52):7594-8. PubMed ID: 10602519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the molecular pathogenesis of extraskeletal myxoid chondrosarcoma-cytogenetic, molecular genetic, and cDNA microarray analyses.
    Sjögren H; Meis-Kindblom JM; Orndal C; Bergh P; Ptaszynski K; Aman P; Kindblom LG; Stenman G
    Am J Pathol; 2003 Mar; 162(3):781-92. PubMed ID: 12598313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a novel fusion gene involving hTAFII68 and CHN from a t(9;17)(q22;q11.2) translocation in an extraskeletal myxoid chondrosarcoma.
    Attwooll C; Tariq M; Harris M; Coyne JD; Telford N; Varley JM
    Oncogene; 1999 Dec; 18(52):7599-601. PubMed ID: 10602520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular analysis of the fusion of EWS to an orphan nuclear receptor gene in extraskeletal myxoid chondrosarcoma.
    Brody RI; Ueda T; Hamelin A; Jhanwar SC; Bridge JA; Healey JH; Huvos AG; Gerald WL; Ladanyi M
    Am J Pathol; 1997 Mar; 150(3):1049-58. PubMed ID: 9060841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between clinicopathological features and karyotype in 100 cartilaginous and chordoid tumours. A report from the Chromosomes and Morphology (CHAMP) Collaborative Study Group.
    Tallini G; Dorfman H; Brys P; Dal Cin P; De Wever I; Fletcher CD; Jonson K; Mandahl N; Mertens F; Mitelman F; Rosai J; Rydholm A; Samson I; Sciot R; Van den Berghe H; Vanni R; Willén H
    J Pathol; 2002 Feb; 196(2):194-203. PubMed ID: 11793371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skeletal and extraskeletal myxoid chondrosarcoma: related or distinct tumors?
    Rubin BP; Fletcher JA
    Adv Anat Pathol; 1999 Jul; 6(4):204-12. PubMed ID: 10410173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence of an association between 6q13-21 chromosome aberrations and locally aggressive behavior in patients with cartilage tumors.
    Sawyer JR; Swanson CM; Lukacs JL; Nicholas RW; North PE; Thomas JR
    Cancer; 1998 Feb; 82(3):474-83. PubMed ID: 9452264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fusion of the NH2-terminal domain of the basic helix-loop-helix protein TCF12 to TEC in extraskeletal myxoid chondrosarcoma with translocation t(9;15)(q22;q21).
    Sjögren H; Wedell B; Meis-Kindblom JM; Kindblom LG; Stenman G
    Cancer Res; 2000 Dec; 60(24):6832-5. PubMed ID: 11156374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extraskeletal myxoid chondrosarcoma with neuroendocrine differentiation: a pathologic, cytogenetic, and molecular study of a case with a novel translocation t(9;17)(q22;q11.2).
    Harris M; Coyne J; Tariq M; Eyden BP; Atkinson M; Freemont AJ; Varley J; Attwooll C; Telford N
    Am J Surg Pathol; 2000 Jul; 24(7):1020-6. PubMed ID: 10895826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SMARCB1/INI1 protein expression in round cell soft tissue sarcomas associated with chromosomal translocations involving EWS: a special reference to SMARCB1/INI1 negative variant extraskeletal myxoid chondrosarcoma.
    Kohashi K; Oda Y; Yamamoto H; Tamiya S; Oshiro Y; Izumi T; Taguchi T; Tsuneyoshi M
    Am J Surg Pathol; 2008 Aug; 32(8):1168-74. PubMed ID: 18580682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skeletal and extraskeletal myxoid chondrosarcoma: a comparative clinicopathologic, ultrastructural, and molecular study.
    Antonescu CR; Argani P; Erlandson RA; Healey JH; Ladanyi M; Huvos AG
    Cancer; 1998 Oct; 83(8):1504-21. PubMed ID: 9781944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of molecular genetic detection of chromosome translocations in the differential diagnosis of pediatric sarcomas.
    Dockhorn-Dworniczak B; Schäfer KL; Blasius S; Christiansen H; Koscielniak E; Ritter J; Winkelmann W; Jürgens H; Böcker W
    Klin Padiatr; 1997; 209(4):156-64. PubMed ID: 9293447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coexpression of NOR1 and SIX3 proteins in extraskeletal myxoid chondrosarcomas without detectable NR4A3 fusion genes.
    Hisaoka M; Okamoto S; Yokoyama K; Hashimoto H
    Cancer Genet Cytogenet; 2004 Jul; 152(2):101-7. PubMed ID: 15262426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extraskeletal myxoid chondrosarcoma: multimodal diagnosis and identification of a new cytogenetic subgroup characterized by t(9;17)(q22;q11).
    Bjerkehagen B; Dietrich C; Reed W; Micci F; Saeter G; Berner A; Nesland JM; Heim S
    Virchows Arch; 1999 Nov; 435(5):524-30. PubMed ID: 10592057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fusion of the EWS-related gene TAF2N to TEC in extraskeletal myxoid chondrosarcoma.
    Sjögren H; Meis-Kindblom J; Kindblom LG; Aman P; Stenman G
    Cancer Res; 1999 Oct; 59(20):5064-7. PubMed ID: 10537274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IDH1 mutations are not found in cartilaginous tumours other than central and periosteal chondrosarcomas and enchondromas.
    Damato S; Alorjani M; Bonar F; McCarthy SW; Cannon SR; O'Donnell P; Tirabosco R; Amary MF; Flanagan AM
    Histopathology; 2012 Jan; 60(2):363-5. PubMed ID: 22074484
    [No Abstract]   [Full Text] [Related]  

  • 19. Translocation t(9;22)(q22;q12) is a primary cytogenetic abnormality in extraskeletal myxoid chondrosarcoma.
    Stenman G; Andersson H; Mandahl N; Meis-Kindblom JM; Kindblom LG
    Int J Cancer; 1995 Aug; 62(4):398-402. PubMed ID: 7635565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. t(9;22)(q22-31;q11-12) is a consistent marker of extraskeletal myxoid chondrosarcoma: evaluation of three cases.
    Sciot R; Dal Cin P; Fletcher C; Samson I; Smith M; De Vos R; Van Damme B; Van den Berghe H
    Mod Pathol; 1995 Sep; 8(7):765-8. PubMed ID: 8539235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.